Stockreport

TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF Engaged CDMO with global capabilities to support manufacturing for pivotal trials and commercialization On-track to report initial data from the solid tumor program a [Read more]